Ekso Bionics (NASDAQ:EKSO) Posts Earnings Results, Misses Expectations By $0.07 EPS

Ekso Bionics (NASDAQ:EKSO) issued its quarterly earnings results on Monday. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.07), Zacks reports. The firm had revenue of $5.09 million for the quarter, compared to analyst estimates of $5.05 million. Ekso Bionics had a negative net margin of 62.95% and a negative return on equity of 83.09%.

Ekso Bionics Price Performance

EKSO stock opened at $0.48 on Tuesday. The stock has a 50-day moving average price of $0.61 and a two-hundred day moving average price of $0.83. Ekso Bionics has a 1 year low of $0.45 and a 1 year high of $2.16. The stock has a market cap of $10.61 million, a PE ratio of -0.74 and a beta of 1.46. The company has a current ratio of 2.81, a quick ratio of 2.14 and a debt-to-equity ratio of 0.28.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on EKSO. StockNews.com began coverage on shares of Ekso Bionics in a research note on Monday. They set a “hold” rating for the company. HC Wainwright restated a “buy” rating and set a $9.00 target price on shares of Ekso Bionics in a research report on Tuesday, January 14th.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.